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Abstract
Purpose
To examine the effect of α-actinin-3 deficiency due to homozygosity for the ACTN3 577X-
allele on contractile and morphological properties of fast muscle fibers in non-athletic young
men.
Methods
A biopsy was taken from the vastus lateralis of 4 RR and 4 XX individuals to test for differ-
ences in morphologic and contractile properties of single muscle fibers. The cross-sectional
area of the fiber and muscle fiber composition was determined using standard immunohis-
tochemistry analyses. Skinned single muscle fibers were subjected to active tests to deter-
mine peak normalized force (P0), maximal unloading velocity (V0) and peak power. A
passive stretch test was performed to calculate Young’s Modulus and hysteresis to assess
fiber visco-elasticity.
Results
No differences were found in muscle fiber composition. The cross-sectional area of type IIa
and IIx fibers was larger in RR compared to XX individuals (P<0.001). P0 was similar in both
groups over all fiber types. A higher V0 was observed in type IIa fibers of RR genotypes
(P<0.001) but not in type I fibers. The visco-elasticity as determined by Young’s Modulus
and hysteresis was unaffected by fiber type or genotype.
Conclusion
The greater V0 and the larger fast fiber CSA in RR compared to XX genotypes likely contrib-
ute to enhanced whole muscle performance during high velocity contractions.
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1. Introduction
The sarcomeric α-actinins are important structural components of the Z-line where they form
the cross-link between the thin actin filaments from adjacent sarcomeres [1]. In addition to
their structural function, α-actinins also interact with several structural, signaling and meta-
bolic proteins. In humans, two genes encode for skeletal muscle α-actinins: ACTN2, which is
expressed in all skeletal muscle fibers and ACTN3 of which the expression is restricted to type
II fibers [2], predominantly involved in powerful explosive contractions.
Worldwide, an estimated 16% of the human population is completely α-actinin-3 protein
deficient due to homozygosity for a common stopcodon polymorphism in the ACTN3 gene
called R577X (rs1815739) [3]. This deficiency does not result in a disease phenotype or muscu-
lar functional impairment, likely through a compensatory upregulation of the homologous α-
actinin-2 protein. However, a number of studies have provided data to indicate that there is a
strong association between the ACTN3 R577X polymorphism and performance in multiple
athletic cohorts. The R-allele has been found to be overrepresented in power athletes compared
to the average population [4,5]. In non-athletic populations, young RR men perform better on
tasks with an explosive strength component compared to XX genotypes, including short
sprints, squat jump and fast isokinetic movements [6,7,8], although not all studies confirm
these genotype-dependent differences [9,10,11,12].
The mechanisms by which α-actinin-3 alters skeletal muscle function are still under study.
The absence of α-actinin-3 in fast (type II) fibers may change the contractile and/or morpho-
logical properties of these fibers and consequentially the characteristics of the whole muscle,
including maximal force, the force-velocity relationship and muscular fatigability. The Actn3-/-
knockout mouse model has provided evidence for this theory. At the whole muscle level, the
KO mice show lower muscle mass, decreased muscle strength, a longer time to exhaustion and
an enhanced recovery from fatigue, alterations which are thought to be the result of observed
changes at the single fiber level [13,14]. The KO fast muscle fibers have a higher activity of aer-
obic enzymes, a delayed Ca2+ loading of the sarcoplasmic reticulum and a smaller diameter
compared to fast fibers of wild mice [13,14].
A previous study in our lab has already determined differences in single muscle fiber charac-
teristics between ACTN3 R577X genotypes in three individuals with spinal cord injury (SCI).
The R-allele carriers showed a higher maximal unloaded velocity and a higher stiffness in their
type IIa/IIx fibers compared to the XX genotype [15]. Yet, it has to be noted that immobilized
muscles of individuals with SCI undergo marked changes [16], such as notably lower muscle
mass and a higher percentage of type II fibers compared to able-bodied individuals. Also, their
type II fibers are smaller, but have a greater contraction velocity and force production com-
pared to able-bodied controls [17]. Therefore, the differences between RR and XX genotypes
found in individuals with SCI can probably not be extrapolated to able-bodied individuals.
This study therefore aims to analyze skinned single muscle fibers to get more insight into
the contractile and morphological properties of α-actinin-3 deficient and α-actinin-3 express-
ing muscle fibers in non-athletic young males. No differences are expected in type I fibers as α-
actinin-3 is only present in type II fibers. Therefore, these fibers can be used as controls to cer-
tify equality between groups. Based on the hypothesized function of the α-actinin-3 protein
and the properties of type II fibers, it is expected that fast fibers of RR individuals will have a
higher maximal force output and a greater (maximal) velocity of shortening compared to XX
fast fibers. Also, the diameter of XX fast fibers is hypothesized to be smaller, based on KO mice
showing a smaller type IIb fiber diameter. The higher stiffness of RR fast fibers in the paraplegic
study may also be present in this group of able-bodied young men.
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2. Methods
2.1 Participants
Eight non-athletic young men (age 20.9±0.7 yr) were selected out of a total group of 266 partic-
ipants based on their characteristics, including stature, weight, physical activity level and maxi-
mal isometric knee extension torque at 45° knee flexion (Table 1). Each RR participant was
matched with the XX participant that most resembled the results on the previous characteris-
tics. Physical activity level was determined during an interview to determine the amount and
type of activities of the participants. Besides sports activities at recreational level, all subjects
reported low levels of physical activity as university/high-shool students during daytime and
leisure time. Static (45° knee flexion) and concentric (300°/s) torques of the knee-extensor
muscles were determined on a self-constructed computerized active isokinetic dynamometer
(servomotor SEW Eurodrive CM90, Bruchsol, Germany) as previously described [7]. Cross-
sectional area of the quadriceps muscle was estimated based on the circumference of the mid-
thigh corrected for subcutaneous fat at this location using the equation of Housh et al. [18].
Informed consent was obtained from all individual participants included in the study. All par-
ticipants volunteered and gave written consent to participate in this study, the protocol of
which had been approved by the Medical Ethics Committee UZ KU Leuven. All experiments
complied with the principles of the Declaration of Helsinki and its subsequent amendments.
2.2 Muscle Biopsies
The needle biopsy method with suction was used to obtain a sample from the vastus lateralis of
the left leg. All participants were asked to retain from intense physical activity three days before
the biopsy. A small part of the muscle biopsy was embedded in Tissue-Tek and frozen in nitro-
gen-cooled isopentane for immunohistochemical analyses. Muscle cryosections were immuno-
histochemically stained for myosin heavy chain isoforms determination as previously
described [7]. The samples used for single fiber testing were immediately placed in cold (0°C)
skinning solution and sectioned longitudinally in small bundles of fibers [19]. The bundles
were stored in regularly replaced skinning solution at –20°C for at least 5 days before the first
experiment. Composition of all solutions can be found in Malisoux et al. (2007).
2.3 Single Muscle Fiber Experiments
After skinning, single muscle fibers were evaluated either for peak activated force normalized
for fiber cross-sectional area (P0), maximal unloaded velocity (V0) and force-velocity
Table 1. Characteristics of the ACTN3 577RR and 577XX genotype groups.
RR n = 4 XX n = 4 P-value ES CI
Age, yr 20.1±1.8 21.7±2.2 0.29 -0.71 [-2.14–0.72]
Stature, cm 176.2±4.4 174.5±7.8 0.71 0.24 [-1.15–1.63]
Weight, kg 68.4±8.6 65.7±11.4 0.72 0.23 [-1.16–1.62]
CSA m. quadriceps 62.5±13.3 61.5±1.5 0.89 0.09 [-1.30–1.47]
Sport participation, h/week 4.1±1.4 4.6±2.2 0.72 -0.46 [-1.86–0.95]
Isometric knee torque at 45°, Nm 180±35 182±31 0.95 -0.04 [-1.43–1.34]
Concentric knee torque at 300°/s, Nm 77±23 54±6 0.10 1.18 [-0.32–2.69]
Values are mean±SD. CSA = cross-sectional area; ES = unbiased Effect Size; CI = 95% confidence interval of the ES
doi:10.1371/journal.pone.0150594.t001
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relationship or passive tension characteristics on a dynamic force set-up. All experiments were
performed at 15°C within four weeks after the biopsy was taken. Detailed protocols have been
previously described [17,19]. In short, single fiber dimensions including fiber length and cross-
sectional area (CSA) were determined on a numeric picture of the fiber after adjustment of sar-
comere length to 2.5 μm. Each fiber was visually checked for damage due to cutting or handling
of the muscle biopsy resulting in the elimination of damaged fibers prior to testing to exclude
an effect on fiber contractile properties. P0 was determined as the stable maximal force devel-
oped by the fiber while submerged in activating solution (pCa 4.5) corrected for fiber CSA. The
unloaded shortening velocity (V0) was measured by the slack test; each fiber was maximally
activated and then rapidly shortened, such that force fell to baseline and redeveloped after a
time lapse, proportional to the step length. Fiber V0 was determined as the slope of the fitted
line and was expressed in fiber lengths per second (FL/s) to account for differences in the num-
ber of sarcomeres in series between different fibers tested. To determine the force-velocity rela-
tionship, the fiber was subjected 5–6 times to three successive isotonic load clamps. The data
obtained on a single fiber were fitted using an iterative nonlinear curve-fitting procedure (Mar-
quardt-Levenberg algorithm) based on the Hill equation. Fiber power (W/l) was determined
from the parameters of the fitted force-velocity curve relationship. Passive tension was tested
with a progressive stretch-release protocol while the fiber remained in the pCa 9.0 solution.
Young's modulus (kN/m2) and hysteresis (kN/m2) were calculated to assess visco-elastic prop-
erties of the fiber. After completion of the mechanical tests, the fiber segment was dissolved in
25 μl of SDS sample buffer, and stored at –20°C until analyzed for MHC isoform content using
SDS-PAGE as previously described [20].
2.4 Genotyping
DNA was extracted from EDTA blood samples at UZ Leuven using chemagic Magnetic Sepa-
ration Module I following the protocol of the manufacturer (PerkinElmer, Baesweiler, Ger-
many). Genotyping of the ACTN3 R577X polymorphism (rs. 1815739) was performed using a
TaqMan SNP genotyping assay (ID C__590093_1, Applied Biosystems). Real-time qPCR was
carried out in a 20 μl reaction mixture with 1 μl DNA, 8 μl RNase-free water, 1 μl of 20× Taq-
Man SNP genotyping assay mix, and 10 μl of the 2× Taqman universal PCR master mix
(Applied Biosystems). All reactions were set up manually, and allele calling was done using
SDS 1.3 software and visually checked.
2.5 Statistical Analyses
Participant characteristics and muscle fiber composition were compared between ACTN3
577RR and 577XX individuals using a Student’s t-test. Single fiber measurements were com-
pared per fiber type between the two genotype groups using ANOVA analyses in SAS version
9.2 (SAS Institute, Cary, NC). A proc mixed procedure with a multilevel model was used to
account for dependency of multiple fibers within one participant. Unbiased effect sizes and
95% confidence intervals for the genotype differences are reported. Only type I and type IIa
fibers were numerous enough to allow statistical analyses. Data for hybrid fibers is presented in
S1 Table. Scores beyond three standard deviations from the mean were considered to be outli-
ers. These scores are discarded in further analyses. Only one test result obtained from a type IIa
fiber from an RR participant was excluded with a Young’s Modulus of 213.2 kN/m² (Total
group mean = 20.5 kN/m²).
Optimal Design Plus Empirical Evidence version 3.01 (William T. Grant Foundation, NY,
NY) was used to estimate the power of the study.
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3. Results
3.1 Participant characteristics
Participant characteristics for the matched ACTN3 577RR and 577XX participants are pre-
sented in Table 1. No differences were found in anthropometric measurements between both
groups. Furthermore, the hours of sport practice per week and the isometric knee torque were
similar between both groups.
3.2 Muscle fiber composition
A total of 1203 fibers were analyzed with an average count of 150 fibers per participant ranging
from 54 to 178 fibers. On average, the relative surface area of type I, type IIa and type IIx fibers
was 53% (25.6–64.5%), 41.5% (23.5–65.6%) and 5.5% (0.5–12.0%) respectively in the total
group (Table 2). No genotype-specific differences were found for the relative surface area or
the proportion of the three fiber types. The cross-sectional area (CSA) of type IIa and type IIx
fibers was significantly larger in the RR compared with the XX participants. The CSA of type I
fibers were similar for both groups (Table 2).
Table 2. Type I, type IIa and type IIx muscle fiber properties of ACTN3 577RR and 577XX genotypes.
RR XX P-value ES CI
Type I
Proportion, % 56±9 53±5 0.79 0.18 [-1.23–1.54]
Relative surface area, % 53±9 53±4 0.96 0.03 [-1.36–1.42]
CSA, μm² 2993±53 2968±51 0.74 0.03 [-0.12–0.17]
P0, kN/m² 163.7±5.3 161.3±5.2 0.53 0.02 [-0.43–0.46]
V0, FL/s 0.97±0.05 1.12±0.03 0.59 -0.54 [-0.98 –-0.11]
Peak power, W/l 3.03±0.22 2.98±0.11 0.50 0.05 [-0.40–0.49]
Young’s modulus, kN/m² 23.7±1.9 21.2±4.4 0.99 0.14 [-0.39–0.67]
Hysteresis, kN/m² 1.64±0.19 1.55±0.36 0.99 0.06 [-0.61–0.50]
Type IIa
Proportion, % 38±8 42±4 0.68 -0.24 [-1.63–1.15]
Relative surface area, % 40±9 43±3 0.82 -0.12 [-1.51–1.26]
CSA, μm² 4312±129 3207±46 <0.001 0.84 [0.33–1.34]
P0, kN/m² 210.1±7.0 184.9±4.8 0.32 0.73 [0.25–1.19]
V0, FL/s 4.07±0.18 3.25±0.16 0.001 0.74 [0.28–1.19]
Peak power, W/l 13.5±0.7 10.1±0.6 0.26 0.86 [0.39–1.33]
Young’s modulus, kN/m² 19.3±1.7 21.7±1.7 0.34 -0.32 [-0.92–0.32]
Hysteresis, kN/m² 1.22±0.17 1.21±0.13 0.95 0.02 [-0.60–0.64]
Type IIx
Proportion, % 6±2 5±2 0.68 0.24 [-1.16–1.63]
Relative surface area, % 6±2 5±2 0.61 0.33 [-1.07–1.72]
CSA, μm² 3982±202 2943±107 <0.001 1.21 [1.01–1.42]
P0, kN/m² 223.9±16.2 189.4±15.0 0.35 0.80 [-0.69–2.80]
V0, FL/s 5.66±0.71 5.09±0.76 0.89 0.33 [-1.00–1.65]
Peak power, W/l 18.8±8.3 9.1±3.1 0.29 1.21 [-0.34–2.75]
Young’s modulus, kN/m² n.a. 18.0±1.3 n.a. n.a. n.a.
Hysteresis, kN/m² n.a. 1.25±0.22 n.a. n.a. n.a.
Values are means±SE; ES = unbiased effect size; CI = 95% confidence interval of ES; n.a. = not applicable
doi:10.1371/journal.pone.0150594.t002
ACTN3 Influences HumanMuscle Fiber Properties
PLOS ONE | DOI:10.1371/journal.pone.0150594 March 1, 2016 5 / 11
3.3 Fiber type-specific P0 and V0
In total, 183 fibers were actively tested of which 79 type I, 3 type I/IIa, 80 type IIa, 12 type IIa/IIx
and 9 type IIx fibers. Overall, peak force normalized for CSA (P0) of type IIa fibers was 21%
higher than in type I fibers (P<0.001). Also, the maximal unloaded velocity (V0) was signifi-
cantly higher in type IIa fibers compared to type I fibers (P<0.001).
P0 and V0 in type I fibers were similar in ACTN3 577RR and 577XX genotypes (P = 0.53; P
= 0.59). In type IIa fibers, V0 was significantly higher in the RR compared to XX genotypes
(P = 0.001). However, P0 did not differ between groups (P = 0.32)(Table 2).
Although force was corrected for fiber CSA, there was a high variability in P0 within each
participant in type I fibers as well as in type IIa fibers. Participant RR#3 showed the highest
range in P0 with scores from 131.7 to 338.2 kN/m² in his type IIa fibers. The highest variability
in V0 was found in type IIa fibers of participant RR#1 with values ranging from 3.23 to 7.07 FL/
s (Fig 1).
In addition, no correlation was found between fiber CSA and V0 in type I (r = 0.01) nor in
type IIa fibers (r = 0.04) (Fig 2).
3.4 Peak power
Overall, peak power was significantly higher in type IIa compared to type I fibers (P<0.001).
There was no difference between ACTN3 577RR and 577XX genotypes in peak fiber power in
type I (P = 0.50) nor in type IIa fibers (P = 0.26).
Fig 1. Results for V0 (FL/s) of type I (A) and type IIa fibers (B), as well as for normalized force (kN/m²) of
type I (C) and type IIa fibers (D) displayed as per participant. RR = filled markers, XX = blank markers.
Matched participants have the samemarker shape. Each individual fiber has the samemarker color in panel
A and C and panel B and D.
doi:10.1371/journal.pone.0150594.g001
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3.5 Passive tension
Passive tension characteristics of single fibers were assessed on a total of 116 fibers of which 54
type I, 43 type IIa, 13 type IIa/IIx and 6 type IIx fibers. No differences were found between type I
and type IIa fibers in the total group regarding the visco-elasticity as determined by Young’s
Modulus (P = 0.53) and hysteresis (P = 0.12). When compared between ACTN3 R577X geno-
types, hysteresis and Young’s Modulus were similar in both type I and IIa fibers (0.34<P<0.99)
(Table 2).
4. Discussion
This study aimed to explore contractile and morphological properties in single muscle fibers
and compare those fiber-type specific characteristics between ACTN3 577RR and 577XX
homozygotes to explain the influence of α-actinin-3 deficiency on whole muscle force. Overall,
the observed values of force, velocity, power and visco-elasticity in skinned muscle fibers were
similar to those previously reported [17,21,22]. As expected, force, velocity and power of type
IIa fibers were higher compared to type I fibers. No genotype-dependent difference was
observed in any of the measured variables of type I fibers, which is in accordance with the
restricted expression of α-actinin-3 to type II fibers.
The absence of α-actinin-3 in fast muscle fibers has been associated with reduced muscle
force, especially during high velocity contractions [7,23,24,25]. Although the concentric knee
torque at 300°/s was on average 11% higher (P<0.05) in RR versus XX subjects in the total
group of 266 participants [23], the 42.5% higher concentric knee torque (300°/s) in the RR
genotypes in this study was non-significant due to a high variability in this variable within
genotype groups.
Both morphologic and contractile components of the muscle can influence the concentric
force production. For instance, whole muscle force is strongly determined by fiber CSA, espe-
cially fast fiber CSA as these fibers have a higher maximal force per μm2 compared to slow
fibers. In this study, type IIa and IIx fibers of ACTN3 577RR genotypes were 14% and 13%
larger than 577XX fibers respectively. Despite the increased fast fiber diameter, no differences
were found in relative surface area of fast fibers between the two groups, which is in line with
Norman et al. (2009)[11], yet in contrast with Vincent et al. (2007)[7]. With similar proportion
of slow and fast fibers, larger fast fibers lead to a larger whole muscle CSA. Although the
Fig 2. Correlation between V0 (FL/s) and fiber CSA of type I (A) and type IIa fibers (B).
doi:10.1371/journal.pone.0150594.g002
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estimated CSA of the quadriceps muscles in this study was similar between genotype groups,
several studies using reference methods observed larger CSA or volume in α-actinin-3 express-
ing muscles of humans and mice [8,13,25,26]. Thus, the larger fast fiber CSA may lead to a
greater muscle volume which may contribute to the higher concentric force production in RR
genotypes.
If the advantage of α-actinin-3 during strength tests was purely related to muscle volume, a
higher isometric force would be expected in RR compared to XX genotypes. Nevertheless, most
studies did not find an effect of the ACTN3 R577X polymorphism on isometric strength of the
leg extensors [7,10,11,23,25,27], suggesting that apart from the higher muscle volume, contrac-
tile properties of the muscle may be altered by the ACTN3 R577X polymorphism. The higher
concentric torque [7,23] and the similar isometric force between genotype groups indicate an
influence of α-actinin-3 deficiency on the preservation of force with increasing velocity rather
than on force itself. Indeed, no differences were found in peak force of isolated type I and type
IIa fibers between genotype groups in this study. In contrast, V0 of type IIa fibers was higher in
ACTN3 577RR compared to 577XX genotypes.
Although the velocity of a muscle fiber mainly depends on its MHC isoform, there is a wide
variability in V0 within a single fiber type [28]. At present, no definitive explanation is available
for this variability, although many potential causes have been considered. An effect of myosin
light chain (MLC) isoforms composition on single muscle fiber velocity has been observed in
rats [29] and humans [30]. Another possibility is the modulation of the functional properties
of myosin [31] by myofibrillar proteins such as titin, troponin and Myosin binding protein C.
Isoforms of α-actinins have been correlated with different expression levels of troponin [32]
and altered binding affinity to titin [33]. Although α-actinin-3 interacts with these proteins,
the present data cannot provide evidence that this is the mechanism by which α-actinin-3-defi-
ciency influences V0.
Fiber V0 is an important determinant of the maximal shortening velocity of the muscle, a
parameter of the force velocity curve. The force-velocity relationship (FVR) is the most critical
muscle contractile property in the limitation of maximal human sprinting speed [34]. A "veloc-
ity-oriented" force-velocity profile is one of the main mechanical determinants of 100-m sprint
performance [35]. In line, Mero et al. (1986) showed evidence for a higher importance of vari-
ables associated with velocity rather than force production capability during sprint [36]. Thus,
the higher fast fiber V0 in RR genotypes may improve sprinting ability, explaining why the
association of the RR genotype with athletic performance is strongest in sprinters [37,38,39].
No difference was found in the visco-elasticity of the fibers as determined by the variables
Young’s Modulus and hysteresis. This is in contrast with the higher stiffness of type IIa/IIx
fibers in ACTN3 577RR compared to 577XX genotypes in a case series study involving paraple-
gic individuals [15]. The reason why the higher fast fiber stiffness is present in the paraplegic
RR muscle is uncertain, but may be related to the changes in muscle fiber properties during
longtime immobilization of the muscle.
Although the statistical analyses were performed on a total of 299 fibers, only eight individu-
als participated in this study. Therefore, the effect size (ES) for the overall comparisons between
XX and RR subjects was reported for each of the measured variables in addition to the p-value.
ES is a simple way to show the actual difference, which is independent of the sample size [40].
In this way the meaningfulness of the differences in fiber contractile properties between
ACTN3 577 RR and XX can be interpreted by the reader (unaffected by the sample size issue).
As expected, effect sizes were small for most fiber contractile properties in type I fibers, ranging
from 0.02 to 0.29, except for V0, which showed a medium ES of -0.54. In contrast, P0 and peak
power of type IIa and IIx fibers showed large effect sizes (0.73–1.21), although null hypothesis
significance testing using the multilevel approach did not reach significance.
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To be thorough, the program Optimal Design Plus Empirical Evidence was used to estimate
the post-hoc power of the study. Based on the number of fibers, subjects, means, within-subject
and between-subject variability for CSA of type IIa fibers, this study reaches a power of 0.49.
Comparisons were performed within a multi-level model approach to account for the
dependency of fibers within each participant. In addition, it cannot be ruled out that structural
differences exist in thin actin filaments between ACTN3 R577X genotypes, which could have
influenced our results. A decrease in actin filament length has been observed after longtime dis-
use of the muscle [41]. As in all studies on isolated fibers, we assumed 2.5μm to be the optimal
sarcomere length.
In conclusion, this study shows that α-actinin-3 deficiency decreases the contraction veloc-
ity of isolated type IIa muscle fibers. The increased cross-sectional area of type IIa and IIx fibers
may explain the increased muscle volume in RR genotypes. Thus, our results suggest that,
rather than fiber force, combined effects of morphological and contractile properties of individ-
ual fast muscle fibers attribute to the enhanced performance observed in RR genotypes during
explosive contractions.
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